drugset / Trial / NCT05091242

The PREVENT AGITATION Trial II - Children ≤1 Year

NCT05091242

Phase 2/3 Unknown 336 enrolled Rigshospitalet, Denmark
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Emergence agitation is a clinical condition in which the child experiences a variety of behavioural disturbances including crying, thrashing, and disorientation during early awakening from anaesthesia. Emergence agitation is a common challenge in children with a reported incidence of approximately 25% ranging from 10 to 80 %. Clonidine is often used off-label in paediatric anaesthesia e.g. sedation in the intensive care unit, prevention of withdrawal symptoms after long-term sedation, as premedication before induction of anaesthesia or as treatment/prevention of emergence agitation. The study is designed as a randomised, placebo-controlled clinical trial evaluating efficacy and safety of a single dose of intraoperative clonidine in children 3-12 months, including pharmacokinetics.

Timeline

Start
2021-10-25
Primary completion
2026-01-31
Completion
2026-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified 3 ug/kg Intravenous

Indications